This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM) and Vera Therapeutics (VERA)

Tipranks - Tipranks - Thu Jul 9, 12:54AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dexcom (DXCM) and Vera Therapeutics (VERA) with bullish sentiments.

55% Off TipRanks

Dexcom (DXCM)

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Dexcom, with a price target of $95.00. The company’s shares closed last Tuesday at $73.57, close to its 52-week low of $62.34.

According to TipRanks.com, Jennings is a 4-star analyst with an average return of 5.2% and a 47.0% success rate. Jennings covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Orchestra BioMed Holdings, and Edwards Lifesciences. ;'>

Dexcom has an analyst consensus of Strong Buy, with a price target consensus of $83.60.

See today’s best-performing stocks on TipRanks >>

Vera Therapeutics (VERA)

TD Cowen analyst Ritu Baral maintained a Buy rating on Vera Therapeutics yesterday and set a price target of $78.00. The company’s shares closed last Tuesday at $42.96.

According to TipRanks.com, Baral is a top 100 analyst with an average return of 44.6% and a 56.2% success rate. Baral covers the Healthcare sector, focusing on stocks such as Sagimet Biosciences, Inc. Class A, Praxis Precision Medicines, and Milestone Pharmaceuticals. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Vera Therapeutics with a $80.33 average price target, which is a 98.5% upside from current levels. In a report issued on June 24, Raymond James also maintained a Buy rating on the stock.

Read More on DXCM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).